胃癌细胞株BGC-823,grastic cancer cell line BGC-823
1)grastic cancer cell line BGC-823胃癌细胞株BGC-823
1.Objective:To Investigate the inhibitory effect and mechanisis of combined treatment of the gastrin receptor antagonist proglumide and the selective COX-2 inhibitor celecoxib on cultured human grastic cancer cell line BGC-823 in vitro.目的:探讨胃泌素受体拮抗剂丙谷胺和选择性还氧合酶-2抑制剂塞来昔布对体外培养的人胃癌细胞株BGC-823增殖抑制作用及其机制。
英文短句/例句

1.The Effects Mechanism of Prebiotics on Proliferation of Human Gastric Cells in Vitro;益生元对人胃癌细胞株BGC-823细胞的抑制作用及机制的研究
2.The effects of prebiotics on proliferation of human gastric cells in vitro益生元对人胃癌细胞株BGC-823细胞抑制作用的研究
3.The Inhibitory Effect of Proglumide and Celecoxib on Human Grastic Cancer Cell Line BGC-823丙谷胺、塞来昔布对人胃癌细胞株BGC-823的抑制作用
4.Influence of PKD1 Methylation on the Proliferation and Invasion of Gastric Carcinoma Cells BGC-823蛋白激酶D1甲基化对胃癌细胞株BGC-823增殖侵袭的影响
5.Effect of Macrophage Migration Inhibitory Factor on Proliferation and Apoptosis in Human Gastric Cancer Cell Line BGC-823MIF抑制剂HA对胃癌细胞株BGC-823增殖和凋亡的影响
6.Effects of Gastrin-shRNAs on Gastric Cancer Cell Line BGC-823;胃泌素-shRNAs对胃癌细胞系BGC-823的效应
7.The influence of TGF-β_1 on invasive ability of BGC-823TGF-β_1对胃癌细胞BGC-823侵袭性的影响
8.The Effect of Paclitaxel on the Expression of Cyclooxygenase-2 and P-glycoprotein in Human Gastric Adenocarcinoma Cell Line BGC-823紫杉醇对胃腺癌细胞株BGC-823环氧化酶-2、P-糖蛋白表达的影响
9.The Initial Study on Expression of DNA polβ mRNA in BGC-823 Cell Silenced by siRNA;siRNA干扰胃癌BGC-823细胞中polβ表达的初步研究
10.Mechanism of Apoptosis Induced by Ursolic Acid in Human Gastric Carcinoma BGC-823 Cells;熊果酸诱导人胃癌细胞BGC-823凋亡机制的研究
11.Study on Apoptosis of BGC-823 Cells Induced by Soluble Human TRAIL;可溶性人TRAIL诱导胃癌细胞BGC-823凋亡的研究
12.Biological Effects of Four Kinds of Nanoparticles on Human Gastric Carcinoma Cell Line BGC-8234种纳米颗粒对人胃癌BGC-823细胞的生物学效应
13.In Vitro Effect of Genistein on Gastric Cancer Cell Line BGC-823染料木素对人胃癌细胞BGC-823的实验研究
14.Effects of deoxynivalenol on apoptosis of human gastric carcinoma cell line SGC-7901,BGC-823 in vitroDON对体外培养胃癌细胞SGC-7901、BGC-823凋亡的影响
15.The Clinical Research on Chronic Atrophic Gastritis and Extraorganismal Empirical Study on the Gastric Carcinomatous BGC-823 Cell Strain According to the Zhuodu Theory基于浊毒学说对慢性萎缩性胃炎的临床研究及对胃癌BGC-823细胞株体外实验研究
16.Studies of Extracts from Inonotus Obliquus on Anti-proliferation and Inducing Apoptosis on BGC-823 Human Gastric Cancer Cell Line;桦褐孔菌提取物抑制人胃癌BGC-823细胞株增殖及诱导凋亡的实验研究
17.Mechanisms of Inhibiting Proliferation and Inducing Apoptosis of Human Gastric Cancer Cell Line BGC-823 by Genistein;染料木素抑制人胃癌细胞BGC-823的增殖和诱导细胞凋亡的机制
18.Construct of Gastrin-shRNA Vector and Its Effects on Gastric Cancer Cell Line BGC-823;胃泌素-shRNA表达载体的构建及其对胃癌细胞系BGC-823的效应
相关短句/例句

human gastric carcinoma cells BGC-823人胃癌细胞BGC-823
1.The mechanism of apoptosis in human gastric carcinoma cells BGC-823 induced with recombinant plasmid comprised Hemagglutinin-neuraminidase(HN) gene from newcastle disease virus;新城疫病毒HN基因重组体对人胃癌细胞BGC-823凋亡作用机制研究
3)Human gastric BGC-823 cell人胃癌BGC-823细胞
1.Incubation of human gastric BGC-823 cells with different concentration (15 μ g/ml, 30 μ g/ml and 45 μ g/ml) of EPA and DHA for 48h, then PKC β II were detected by flow cytometry,immuno cytochemistry and Western blot.方法:将人胃癌BGC-823细胞分对照组、EPA药物组和DHA 药物组,EPA组和DHA组按15 μ g/ml、30 μ g/ml、45μ g/ml加药,肿瘤细胞培养48小时后,用流式细胞仪测定胃癌细胞PKC β II蛋白含量(鼠抗人PKC βⅡ抗体,1:50),以荧光指数(Flurorescene Index,FI)表示蛋白相对含量:FI= {样品蛋白表达的平均荧光强度/正常对照样品平均荧光强度} ×100%。
2.Incubation of human gastric BGC-823 cells with different concentration (15 μ g/ml, 30 μ g/ml and 45 μ g/ml) of EPA and DHA for 48h,then NF- κ B p65 were detected by immuno cytochemistry, Western blot and TR-PCR.方法:将人胃癌BGC-823细胞分对照组、 EPA药物组和DHA药物组,EPA组和DHA组按15 μg/ml、 30 μ g/ml和45 μg/ml药物浓度加药,肿瘤细胞加药继续培养48小时后,用SP-9000免疫细胞化学检测胃癌细胞NF- κ B p65蛋白分布(鼠抗人NF κ B p65单克隆抗体1:100), DAB显色,观察。
3.When human gastric BGC-823 cells were treated by 15 μg/mL,30 μg/mL and 45 μg/mL of EPA and DHA after 48 hours, the techniques were used as follows: arachidonic acid (AA), EPA and DH.本研究通过观察ω-3多不饱和脂肪酸制剂二十碳五烯酸 (cis-5,8,11,14,17-eicosapentaenoic aicd,EPA)和二十二碳六烯酸(cis-4,7,10,13,16,19-docosahexaenoic acid, DHA)对人胃癌BGC-823细胞膜ω-6多不饱和脂肪酸物质花生四烯酸(arachidonic acid,AA)和细胞内前列腺素E2 (PGE2)的影响,探讨ω-3多不饱和脂肪酸对人胃癌BGC- 823细胞的抑制作用机制。
4)BGC-823gastric cancer cellBGC-823胃癌细胞
1.Methods:At first,by high temperature and infection with NDV in vitro to probe into the alteration of morphology and proliferation of BGC-823gastric cancer cells by means of light microscopy and MTT assay.目的:研究加热法及新城疫病毒(NDV)单独或联合体外诱导BGC-823胃癌细胞热休克蛋白70(HSP70)的表达及其意义。
5)human gastric carcinoma cell line BGC-823人胃癌BGC-823细胞
1.Effects of activated carbon nanoparticles on human gastric carcinoma cell line BGC-823 in vitro活性炭纳米粒子对人胃癌BGC-823细胞作用的体外实验研究
2.Objective:To prepare the activated carbon nanoparticles(ACNP) of specific particle size and investigate the effects of ACNP on the human gastric carcinoma cell line BGC-823 in vitro.目的:制备特定粒径范围的纳米活性炭(activated carbon nanoparticles,ACNP),探讨ACNP对人胃癌BGC-823细胞的作用及相关机制;同时,选择与ACNP在同一粒径范围的其他三种纳米颗粒(纳米SiO_2、纳米TiO_2、纳米ZnO),探讨不同化学组成的纳米颗粒对人胃癌BGC-823细胞的生物学效应及作用机制。
6)BGC-823 gastric cancer cells胃癌BGC-823细胞系
延伸阅读

14 Amino Acid Injection-823药物名称:14氨基酸注射液-823英文名:14 Amino Acid Injection-823适应症: 主要用于手术前后、创伤、烧伤、骨折等分解代谢旺盛及低蛋白质血症等病人,由于肠道功能失调引起消化和吸收障碍的病人;由于厌食、拒食或限食等引起蛋白质摄取量不足所致的营养不良者;其他原因引起的慢性消耗性疾病病人。 用量用法: 静脉滴注常用量:1日250~500ml,严重消耗性疾病可增至1000ml。与高渗葡萄糖(25%以上)混匀后经中心静脉插管滴注,与5%~10%葡萄糖注射液混匀后经外周静脉缓慢滴注。滴注速度宜慢,每分钟以20~30滴为宜。 注意事项: 同11氨基酸注射注-833。 规格: 针剂:每瓶250ml、500ml。每100ml中含14氨基酸8.24g。类别:营养药物